Spots Global Cancer Trial Database for Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)
Official Title: International Multi-center Open-label Randomized Clinical Trial of Efficacy, Safety and Pharmacokinetics of BCD-100 (JSC "BIOCAD", Russia) Monotherapy Compared to Docetaxel as Second-line Therapy of Patients With Advanced Inoperable or Metastatic Non-small Cell Lung Cancer
Study ID: NCT03288870
Study Description
Brief Summary: International multi-center open-label randomized clinical trial of efficacy, safety and pharmacokinetics of BCD-100 (JSC BIOCAD, Russia) monotherapy compared to docetaxel as second-line therapy of patients with advanced inoperable or metastatic non-small cell lung cancer
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Gomel Regional Clinical Oncology Dispensary, Gomel, , Belarus
Arkhangelsk District Clinical Oncology Dispensary, Arkhangelsk, , Russian Federation
Clinical Oncology Dispensary N1, Krasnodar, , Russian Federation
N.N. Burdenko General Military Clinical Hospital, Moscow, , Russian Federation
Pyatigorsk Oncology Center, Pyatigorsk, , Russian Federation
Saint Petersburg City Clinical Oncology Center, Saint Petersburg, , Russian Federation
N.N.Petrov Oncology Research Center, St.Petersburg, , Russian Federation
Republican Clinical Oncology Dispensary of Ministry of Health republic Bashkortostan, Ufa, , Russian Federation
Contact Details
Name: Roman A Ivanov, PhD
Affiliation: Vice President R&D, JSC BIOCAD
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
